Inv2, rMce1a (13-34)

General Information


DRACP ID  DRACP05126

Peptide Name   Inv2, rMce1a (13-34)

Sequence  GKYVSLTTPKNPTKRRITPKDV

Sequence Length  22

UniProt ID  Not available

PubChem CID  Not available

Origin  Protein derived

Type  Native peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free (peptide coated FITC labelled microspheres)

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C111H191N33O32

Absent amino acids  ACEFHMQW

Common amino acids  KT

Mass  287467

Pl  11.25

Basic residues  6

Acidic residues  1

Hydrophobic residues  4

Net charge  5

Boman Index  -6236

Hydrophobicity  -113.64

Aliphatic Index  61.82

Half Life 
  Mammalian: 100 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  1490

Absorbance 280nm  70.95

Polar residues  8

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16620748

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  1244

DRACP is developed by Dr.Zheng's team.